Led by dermatologist co-founders Reid Waldman and Tim Durso, Veradermics is developing an oral, non-hormonal treatment for men and women with pattern hair loss, a condition that affects 80 million people in the US, according to a filing Friday with the US Securities and Exchange Commission.
In anticipation of submitting late-stage trial data to gain approval from the US Food and Drug Administration, the company is already preparing to identify patients, educate doctors and begin marketing the product directly to consumers, according to the filing. ...